Compared with non-sarcopenic controls, sarcopenic individuals exhibited lower circulating IGF-I levels and a reduced IGF-I/IGF-binding protein 3 (IGFBP3) ratio, although these differences did not reach statistical significance.
← all excerpts
A review of omics studies in sarcopenia: from molecular mechanisms to hepatic-gut-muscle interactions in chronic liver disease comorbidity.
1
—
—